A brand new coronavirus variant is circulating, probably the most transmissible one but. Hospitalizations of contaminated sufferers are rising. And older adults symbolize practically 90% of U.S. deaths from COVID-19 in latest months, the most important portion because the begin of the pandemic.
What does that imply for individuals 65 and older catching COVID for the primary time or these experiencing a repeat an infection?
The message from infectious illness specialists and geriatricians is obvious: Search therapy with antiviral remedy, which stays efficient towards new COVID variants.
The remedy of first selection, specialists mentioned, is Paxlovid, an antiviral therapy for individuals with gentle to average COVID at excessive threat of turning into significantly in poor health from the virus. All adults 65 and up fall in that class. If individuals can’t tolerate the medicine — potential issues with different medication must be rigorously evaluated by a medical supplier — two options can be found.
“There’s numerous proof that Paxlovid can cut back the danger of catastrophic occasions that may comply with an infection with COVID in older people,” mentioned Dr. Harlan Krumholz, a professor of medication at Yale College.
In the meantime, develop a plan for what you’ll do for those who get COVID. The place will you search care? What for those who can’t get in rapidly to see your physician, a typical drawback? It’s good to act quick since Paxlovid have to be began no later than 5 days after the onset of signs. Will it’s worthwhile to alter your medicine routine to protect towards doubtlessly harmful drug interactions?
“The time to be figuring all this out is earlier than you get COVID,” mentioned Dr. Allison Weinmann, an infectious-disease professional at Henry Ford Hospital in Detroit.
Being ready proved important once I caught COVID in mid-December and went to pressing look after a prescription. As a result of I’m 67, with blood most cancers and autoimmune sickness, I’m at elevated threat of getting severely in poor health from the virus. However I take a blood thinner that may have life-threatening interactions with Paxlovid.
Fortuitously, the pressing care heart may see my digital medical document, and a doctor’s notice there mentioned it was secure for me to cease the blood thinner and get the therapy. (I’d consulted with my oncologist prematurely.) So, I walked away with a Paxlovid prescription, and inside a day my complications and chills had disappeared.
Simply earlier than getting COVID, I’d learn an vital examine of practically 45,000 sufferers 50 and older handled for COVID between January and July 2022 at Mass Normal Brigham, a big Massachusetts well being system. Twenty-eight p.c of the sufferers had been prescribed Paxlovid, which had acquired an emergency use authorization for gentle to average COVID from the FDA in December 2021; 72% weren’t. All had been outpatients.
In contrast to in different research, a lot of the sufferers on this one had been vaccinated. Nonetheless, Paxlovid conferred a notable benefit: Those that took it had been 44% much less more likely to be hospitalized with extreme COVID-related sicknesses or die. Amongst those that’d gotten fewer than three vaccine doses, these dangers had been decreased by 81%.
Just a few months earlier, a examine out of Israel had confirmed the efficacy of Paxlovid — the model title for a mixture of nirmatrelvir and ritonavir — in seniors contaminated with COVID’s omicron pressure, which arose in late 2021. (The unique examine establishing Paxlovid’s effectiveness had been performed whereas the delta pressure was prevalent and included solely unvaccinated sufferers.) In sufferers 65 and older, most of whom had been vaccinated or beforehand had COVID, hospitalizations had been decreased by 73% and deaths by 79%.
Nonetheless, a number of components have obstructed Paxlovid’s use amongst older adults, together with medical doctors’ issues about drug interactions and sufferers’ issues about potential “rebound” infections and negative effects.
Dr. Christina Mangurian, vice dean for school and tutorial affairs on the College of California-San Francisco Faculty of Medication, encountered a number of of those points when each her mother and father caught COVID in July, an episode she chronicled in a latest JAMA article.
First, her father, 84, was advised in a digital medical appointment by a health care provider he didn’t know that he couldn’t take Paxlovid as a result of he’s on a blood thinner — a choice later reversed by his main care doctor. Then, her mom, 78, was advised, in a separate digital appointment, to take an antibiotic, steroids, and over-the-counter medicines as an alternative of Paxlovid. As soon as once more, her main care physician intervened and provided a prescription.
In each circumstances, Mangurian mentioned, the medical doctors her mother and father first noticed appeared to misconceive who ought to get Paxlovid, and below what situations. “This factors to a serious deficit when it comes to how details about this remedy is being disseminated to front-line medical suppliers,” she advised me in a cellphone dialog.
Michael Osterholm, director of the Middle for Infectious Illness Analysis and Coverage on the College of Minnesota, agrees. “Day by day, I hear from people who find themselves misinformed by their physicians or call-in nurse traces. Usually, they’re being advised you’ll be able to’t get Paxlovid till you’re significantly in poor health — which is simply the other of what’s beneficial. Why are we not doing extra to teach the medical group?”
The potential for drug interactions with Paxlovid is a major concern, particularly in older sufferers with a number of medical situations. Greater than 120 medicines have been flagged for interactions, and every case must be evaluated, considering a person’s situations, in addition to kidney and liver operate.
The excellent news, specialists say, is that almost all potential interactions will be managed, both by briefly stopping a drugs whereas taking Paxlovid or decreasing the dose.
“It takes just a little additional work, however there are assets and methods in place that may assist practitioners determine what they need to do,” mentioned Brian Isetts, a professor on the College of Minnesota Faculty of Pharmacy.
In nursing houses, sufferers and households ought to ask to talk to advisor pharmacists in the event that they’re advised antiviral remedy isn’t beneficial, Isetts recommended.
About 10% of sufferers can’t take Paxlovid due to potential drug interactions, in response to Dr. Scott Dryden-Peterson, medical director of COVID outpatient remedy for Mass Normal Brigham. For them, Veklury (remdesivir), an antiviral infusion remedy delivered on three consecutive days, is an effective choice, though typically troublesome to rearrange. Additionally, Lagevrio (molnupiravir), one other antiviral capsule, may also help shorten the length of signs.
Many older adults concern that after taking Paxlovid they’ll get a rebound an infection — a sudden resurgence of signs after the virus appears to have run its course. However within the overwhelming majority of circumstances “rebound could be very gentle and signs — normally runny nostril, nasal congestion, and sore throat — go away in a number of days,” mentioned Dr. Rajesh Gandhi, an infectious-disease doctor and professor of medication at Harvard Medical Faculty.
Gandhi and different physicians I spoke with mentioned the danger of not treating COVID in older adults is much better than the danger of rebound sickness.
Unwanted side effects from Paxlovid embody a metallic style within the mouth, diarrhea, nausea, and muscle aches, amongst others, however critical issues are unusual. “Persistently, persons are tolerating the drug rather well,” mentioned Dr. Caroline Harada, affiliate professor of geriatrics on the College of Alabama-Birmingham Heersink Faculty of Medication, “and feeling higher in a short time.”
We’re keen to listen to from readers about questions you’d like answered, issues you’ve been having along with your care, and recommendation you want in coping with the well being care system. Go to khn.org/columnists to submit your requests or suggestions.
KHN (Kaiser Well being Information) is a nationwide newsroom that produces in-depth journalism about well being points. Along with Coverage Evaluation and Polling, KHN is without doubt one of the three main working packages at KFF (Kaiser Household Basis). KFF is an endowed nonprofit group offering info on well being points to the nation.